Choline is essential in diets fed to most young vertebrates, but previous studies did not confirm the essentiality of choline in diets fed to tilapia. Two experiments were conducted to evaluate the essentiality of dietary choline in such diets. The basal diet used in both experiments contained 32 g crude protein/100 g diet (10.1 g crude protein from casein and gelatin, and 21.9 g from a crystalline L-amino acid mixture). The total sulfur amino acid (TSAA) concentration of the basal diet was 0.28 g/100 g diet, Met:Cys 89:11. In Experiment 1, a 4x2 design was used in which crystalline L-methionine was added to the basal diet resulting in four levels of TSAA (0.28, 0.50, 0.75 or 1.0 g/100 g diet, Met:Cys 89:11, 94:6, 96:4, or 97:3, respectively). At each level of TSAA, diets also contained either 0 or 1 g choline/kg diet supplied as choline chloride. Weight gain, feed efficiency (FE) and serum methionine concentrations were significantly affected by dietary TSAA concentration, but not by dietary choline concentration or the interaction between TSAA and choline. Weight gain, feed efficiency and serum methionine concentrations indicated that the TSAA requirement was 0.5 g/100 g diet. In the second experiment, diets were formulated to contain either 0.28 or 0.5 g TSAA/100 g diet, Met:Cys 89:11 or 94:6, respectively, and graded levels of choline ranging from 1 to 4 g/kg diet in gradations of 1 g/kg. Dietary methionine significantly affected weight gain and FE, whereas dietary choline significantly affected weight gain, FE and survival, and the interaction of methionine and choline significantly affected weight gain. Fish fed diets containing 0.5 g TSAA/100 g diet and 3 g choline chloride/kg diet exhibited the highest weight gain, feed efficiency and survival. On the basis of these data, it seems clear that juvenile tilapia require choline in certain dietary formulations.
We hypothesize: (a) peripheral innervation densities determine map scales in dorsal horn, (b) dorsal horn cell (DHC) receptive field (RF) geometries are determined by map scales, and (c) morphologies of primary afferents (PAs) and DHCs reflect their developmental history. We suggest the following sequence: (A) PAs project in a somatotopic mediolateral sequence. (B) DHCs assemble prototype RFs by sampling presynaptic neuropil with their dendrites. (C) PAs then project to all levels where their RFs are contained within prototype RFs of DHCs. (D) A competitive mechanism produces the adult form of DHC RFs. (E) Adult distributions of PA terminals and DHC dendrites reflect this developmental history. (F) Mediolateral somatotopic gradients are determined by RF densities of axons entering at the same levels. (G) Map scales at different rostrocaudal levels are determined by somatotopic gradients. (H) Geometries of DHC RFs are determined by constant convergence and divergence of monosynaptic connections. (I) Secondary processes further modify geometries of DHC RFs. (J) Residual self-organizing capacity supports maintenance and plastic mechanisms. We adduce the following evidence: (1) agreement between monosynaptically coupled inputs and cells' excitatory low threshold mechanoreceptive fields; (2) the temporal sequence of events during penetration of the gray matter by PAs; (3)variation of PA terminal and DHC dendritic domains as a function of map scale; (4) somatotopic gradients and geometries of DHC RFs in adult dorsal horn; (5) calculations of peripheral innervation densities and dorsal horn map scales; and (6) constant divergence and convergence between PAs and DHCs.
Previous studies in this laboratory have shown 1) that 19% of L6 and L7 dorsal horn cells in normal cats respond only with excitatory postsynaptic potentials (EPSPs) to sural nerve stimulation, and 2) that the distribution of dorsal horn neurons responding with impulses to sural nerve stimulation is increased in cats with chronic lateral funiculus lesions. The present study was undertaken to determine whether strengthening of subliminal sural nerve projections could account for the changes seen after lateral funiculus lesions and to explore the nature of these changes in greater detail. Ipsilateral L6 and L7 dorsal horn cells of cats with T12 dorsolateral funiculus (DLF) lesions were studied electrophysiologically at less than 1-30 days postoperatively (DPO) and were compared with similar cells recorded in normal cats. The major results were as follows. 1. Responsiveness to peripheral stimulation was depressed for up to 3 DPO following the lesions. 2. The percentage of L6 and L7 dorsal horn cells showing spontaneous activity was elevated at 3 DPO and declined to normal levels by 28 DPO. 3. The percentage of cells that responded to sural nerve stimulation increased over 3-30 DPO and was significantly greater than normal at 28-30 DPO. The increase in the percentage of cells giving impulses to sural nerve stimulation at 28-30 DPO was similar to the percentage of cells with subliminal responses to sural nerve stimulation in normal cats. A subpopulation of identified postsynaptic dorsal column neurons also showed a significant increase in the percentage that responded to sural nerve stimulation after DLF lesions. 4. The percentage of cells that had a cutaneous receptive field (RF) overlapping the region of skin innervated by the sural nerve also increased over time and was significantly greater than normal at 28-30 DPO. 5. Median low-threshold or high-threshold RF areas were not significantly greater than normal ipsilateral to DLF lesions at any survival time. 6. The proportions of low-threshold (LT), high-threshold (HT), and multireceptive (MR) cells were not significantly different from normal at any survival time from less than 1 to 30 DPO.(ABSTRACT TRUNCATED AT 400 WORDS)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.